Cargando…

Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer’s disease brains

INTRODUCTION: The identification of multiple genetic risk factors for Alzheimer’s disease (AD) suggests that many pathways contribute to AD onset and progression. However, the metabolomic and lipidomic profiles in carriers of distinct genetic risk factors are not fully understood. The metabolome can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novotny, Brenna C., Fernandez, Maria Victoria, Wang, Ciyang, Budde, John P., Bergmann, Kristy, Eteleeb, Abdallah M., Bradley, Joseph, Webster, Carol, Ebl, Curtis, Norton, Joanne, Gentsch, Jen, Dube, Umber, Wang, Fengxian, Morris, John C., Bateman, Randall J., Perrin, Richard J., McDade, Eric, Xiong, Chengjie, Chhatwal, Jasmeer, Goate, Alison, Farlow, Martin, Schofield, Peter, Chui, Helena, Karch, Celeste M., Cruchaga, Carlos, Benitez, Bruno A., Harari, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106526/ https://www.ncbi.nlm.nih.gov/pubmed/36251323 http://dx.doi.org/10.1002/alz.12800

Ejemplares similares

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2021)

Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2022)

An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations
por: Dube, Umber, et al.
Publicado: (2019)

Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
por: Brase, Logan, et al.
Publicado: (2023)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network
por: Karch, Celeste M., et al.
Publicado: (2018)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis
por: Tang, Mengxuan, et al.
Publicado: (2016)

Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure
por: Li, Zeran, et al.
Publicado: (2018)

Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP
por: Jiang, Shan, et al.
Publicado: (2018)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
por: Fernández, Maria Victoria, et al.
Publicado: (2017)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease
por: Fernández, Maria V., et al.
Publicado: (2018)

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
por: Gonneaud, Julie, et al.
Publicado: (2021)

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease
por: Johnson, Erik C. B., et al.
Publicado: (2023)

Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels
por: Ibanez, Laura, et al.
Publicado: (2017)

Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer’s disease in the European American population
por: Kirola, Laxmi, et al.
Publicado: (2021)

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
por: Karch, Celeste M., et al.
Publicado: (2012)

Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal‐dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2023)

MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state
por: You, Shih-Feng, et al.
Publicado: (2023)

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2021)

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling
por: Minaya, Miguel A., et al.
Publicado: (2023)

The informed road map to prevention of Alzheimer Disease: A call to arms
por: McDade, Eric, et al.
Publicado: (2021)

Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
por: Maxwell, Taylor J., et al.
Publicado: (2018)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2021)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2018)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Legionella and the Prevention of Legionellosis
por: McDade, Joseph E.
Publicado: (2008)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_50s3umkbg9ndqtpahfsigj7oa9